Ready when you are
Mechanistically, mono- and poly-ubiquitination of TRIM28 by the RING domain of TRIM37 facilitates the interaction between TRIM28 and TRIM37 and promotes the nuclear accumulation of TRIM37, thereby enabling the TRIM37TRIM28 complex to exert its repressive function
Technical Specifications Compound: BPC-157 (Synthetic Pentadecapeptide) Format: Lyophilized peptide powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White lyophilized powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory experimentation In-vitro scientific research Biochemical and molecular studies Non-human preclinical model development Institutional or academic research programs Not intended for: Human or animal consumption Injection, ingestion, inhalation, or topical use Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada, FDA, or any regulatory authority for clinical use
Prevalence and characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, united states, 2018
Case series and clinical experience reports describe minimal adverse effects with BPC-157 use